Every major medical congress generates a flood of insights — scientific updates, competitor signals, and shifts in KOL influence. Yet within weeks, most of that intelligence is buried in notes, scattered across teams, or never translated into action. The difference comes down to one thing: how effectively you capture insights during sessions and run your post-congress debrief. ... Read this blog
Two medical device companies launch similar products in the same therapeutic area. One achieves rapid clinical adoption. The other struggles to gain traction despite comparable clinical data. The difference is rarely the product. ... Read this blog
Digital transformation has revolutionized many areas of healthcare from diagnostics and digital patient engagement to clinical decision support and telemedicine. ... Read this blog
Digital transformation in healthcare has made it effortlessly simple for pharmaceutical companies to reach out to experts or build compliant, long-term relationships. However, before we can build those relationships, we must first understand the disconnect.
... Read this blog
As CNS healthcare professionals increasingly adopt digital channels for learning, collaboration, and sharing perspectives, engagement strategies must evolve in parallel. ... Read this blog
Analytics are integral to the healthcare ecosystem. But for years, pharmaceutical companies have relied on quantitative, volume-based metrics such as email open rates, click-through rates, and attendance numbers to gauge performance. ... Read this blog
The Central Nervous System (CNS) therapeutic area is one of the most complex and fragmented in modern medicine. It spans dozens of sub-specialities, each with its own set of experts, societies, and evolving body of research. ... Read this blog
The need for KOL mapping best practices has never been greater in the pharmaceutical industry. Implementing best practices is crucial for prioritizing high-impact healthcare professionals, allocating resources strategically, and staying ahead of emerging trends. This supports both clinical and commercial objectives. ... Read this blog
While the pharmaceutical industry is evolving at an unprecedented pace, increasing competition, complex treatment landscapes, and digital transformation have made it difficult for companies to identify and engage the right healthcare professionals (HCPs). ... Read this blog
As leaders in veterinary sciences, you already know that innovation doesn’t move forward on data alone. It takes trusted voices to translate science into practice, and in veterinary science, those voices belong to Key Opinion Leaders (KOLs). ... Read this blog
In the life sciences industry, effective KOL engagement and communication are only as strong as the systems that support them. As teams engage healthcare professionals across regions and navigate compliance requirements, a CRM tailored for medical affairs becomes essential. ... Read this blog
If 2020 was the year healthcare went digital out of necessity, then 2025 is the year it learns to thrive in this digital landscape. Key Opinion Leader (KOL) engagement has been completely reshaped by digital platforms, data-driven strategies, and the mainstream acceptance of Digital Opinion Leaders (DOLs). ... Read this blog
Recommended
